AGuIX nanoparticle-nanobody bioconjugates to target immune checkpoint receptors
Nanoscale. 2024 Feb 1;16(5):2347-2360. doi: 10.1039/d3nr04777f.
L.Carmès, G.Bort, F.Lux, et al.
AGuIX nanoparticle-nanobody bioconjugates to target immune checkpoint receptors
Nanoscale. 2024 Feb 1;16(5):2347-2360. doi: 10.1039/d3nr04777f.
L.Carmès, G.Bort, F.Lux, et al.